Table of Contents
Chapter 1. Global Nuclear Medicine Market Executive Summary
1.1. Global Nuclear Medicine Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Application
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Nuclear Medicine Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Nuclear Medicine Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Chronic Diseases
3.1.2. Technological Advancements
3.1.3. Government and Agency Initiatives
3.2. Market Challenges
3.2.1. Competition from Other Imaging Modalities
3.2.2. Reimbursement Issues
3.3. Market Opportunities
3.3.1. Rising Adoption of AI in Radiopharmaceutical Development
3.3.2. Increasing Investment in R&D
3.3.3. Strategic Collaborations and Product Launches
Chapter 4. Global Nuclear Medicine Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Nuclear Medicine Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Nuclear Medicine Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Diagnostics
5.2.2. Therapeutics
Chapter 6. Global Nuclear Medicine Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Nuclear Medicine Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Neurology
6.2.2. Cardiology
6.2.3. Oncology
6.2.4. Others
Chapter 7. Global Nuclear Medicine Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Nuclear Medicine Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospitals & Clinics
7.2.2. Diagnostic Centers
7.2.3. Others
Chapter 8. Global Nuclear Medicine Market Size & Forecasts by Region 2022-2032
8.1. North America Nuclear Medicine Market
8.1.1. U.S. Nuclear Medicine Market
8.1.1.1. Type breakdown size & forecasts, 2022-2032
8.1.1.2. Application breakdown size & forecasts, 2022-2032
8.1.1.3. End User breakdown size & forecasts, 2022-2032
8.1.2. Canada Nuclear Medicine Market
8.2. Europe Nuclear Medicine Market
8.2.1. UK Nuclear Medicine Market
8.2.2. Germany Nuclear Medicine Market
8.2.3. France Nuclear Medicine Market
8.2.4. Spain Nuclear Medicine Market
8.2.5. Italy Nuclear Medicine Market
8.2.6. Rest of Europe Nuclear Medicine Market
8.3. Asia-Pacific Nuclear Medicine Market
8.3.1. China Nuclear Medicine Market
8.3.2. India Nuclear Medicine Market
8.3.3. Japan Nuclear Medicine Market
8.3.4. Australia Nuclear Medicine Market
8.3.5. South Korea Nuclear Medicine Market
8.3.6. Rest of Asia Pacific Nuclear Medicine Market
8.4. Latin America Nuclear Medicine Market
8.4.1. Brazil Nuclear Medicine Market
8.4.2. Mexico Nuclear Medicine Market
8.4.3. Rest of Latin America Nuclear Medicine Market
8.5. Middle East & Africa Nuclear Medicine Market
8.5.1. Saudi Arabia Nuclear Medicine Market
8.5.2. South Africa Nuclear Medicine Market
8.5.3. Rest of Middle East & Africa Nuclear Medicine Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. GE HealthCare
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Lantheus Holdings, Inc.
9.3.3. Nordion (Canada) Inc. (Sotera Health)
9.3.4. Bracco
9.3.5. Curium
9.3.6. Bayer AG
9.3.7. Siemens Healthineers AG
9.3.8. Novartis AG
9.3.9. Jubilant Pharmova Limited
9.3.10. Cardinal Health
9.3.11. Norgine
9.3.12. DuchemBio, Co., Ltd.
9.3.13. DraxImage,Inc. (Canada)
9.3.14. Eckert & Ziegler (Germany)
9.3.15. Isotope JSC (Russia)
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes